<DOC>
	<DOCNO>NCT00004912</DOCNO>
	<brief_summary>RATIONALE : Megestrol help improve appetite . Exercise may decrease cancer-related fatigue , improve strength , build lose muscle tissue . Exercise plus megestrol may effective treatment cancer-related weight loss . PURPOSE : Phase II trial study effectiveness megestrol plus exercise improve appetite , increase strength , gain lean body tissue , decrease fatigue patient cancer-related weight loss .</brief_summary>
	<brief_title>Megestrol Exercise Treating Patients With Cancer-Related Weight Loss</brief_title>
	<detailed_description>OBJECTIVES : I . Determine effect megestrol progressive resistance train lean body mass , total body weight , functional capacity , appetite , fatigue patient weight loss due advanced malignancy . OUTLINE : This multicenter study . Patients receive oral megestrol daily . Patients also begin progressive resistance train 3 day week . Treatment/exercise continue 12 week absence unacceptable toxicity progressive weight loss ( great 5 pound 5 % first 4 study week ) . PROJECTED ACCRUAL : A total 46 patient accrue study within 1 year .</detailed_description>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Advanced nonhormone responsive malignancy ( metastatic incurable ) Nonvolitional weight loss 69 % usual body weight past 6 month OR Decrease 5 pound past 2 month less ( great 10 % loss usual body weight ) No clinical radiologic evidence ascites pleural effusion No lytic bone metastases PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 01 Life expectancy : At least 4 month Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No venous thrombosis No congestive heart failure Other : Able participate exercise program 1 hour , 3 times/week No physical handicap precludes aerobic resistance exercise No clinical abnormality render exercise risk At least 1 month since strength training 3 hour per week No physical functional obstruction food intake No uncontrolled emesis great 5 episodes/week No diarrhea great 4 stools/day intractable antidiarrheal medication No IV hyperalimentation No contraindication megestrol No dementia mental incompetence No known AIDS Not pregnant nursing Negative pregnancy test PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : No concurrent adrenal steroid ( replacement ) , anabolics , appetite stimulant , progestational agent Intermittent corticosteroid antiemetic premedication cancer treatment allow At least 6 week since prior megestrol Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>fatigue</keyword>
	<keyword>cachexia</keyword>
</DOC>